ISSN: 2578-4625
Authors: Smiti S*, El Majjaoui S, El Allam O, Taouchikht M, Fares H, Laraichi R, El Kacemi H, Kebdani T and Hassouni K
Duration Time of treatment (DTT) in cervical cancer is an essential prognostic factor. Longer treatment duration is the most unfavorable prognostic factor for local control. Objective: The main objective of this study is to investigate the impact of the pandemic on (DTT) in cervical cancer. Through a unicentric retrospective study carried out at the Radiotherapy department of the National Institute of Oncology, for 2 years, before and during the pandemic. Results: The number of patients followed before the pandemic was 138 and 157 during the pandemic. The average age before the pandemic was 54 and 53 during the pandemic. Squamous cell carcinoma accounted for 91% versus 9% adenocarcinoma. The average spread was 53 days before the pandemic, and 51 days during the pandemic. To facilitate patient care, a guest house has been made available to them. And a new system for programming and organizing brachytherapy was launched in July 2019, to control sprawl in these patients, and avoid its extension. Conclusion: Our study has made it possible to assess the impact of the pandemic on sprawling in our patients and the means to overcome the constraints of travel and organization for treatment within the optimal timeframe, in order to ensure a better local control.
Keywords: Cervical Cancer; Duration Time of Treatment; COVID Pandemic
